Literature DB >> 8869466

Immune tolerance for the treatment of factor VIII inhibitors--twenty years' 'bonn protocol'.

H H Brackmann1, J Oldenburg, R Schwaab.   

Abstract

Mesh:

Substances:

Year:  1996        PMID: 8869466     DOI: 10.1111/j.1423-0410.1996.tb01346.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


× No keyword cloud information.
  27 in total

Review 1.  Key issues in inhibitor management in patients with haemophilia.

Authors:  Keith Gomez; Robert Klamroth; Johnny Mahlangu; Maria E Mancuso; María E Mingot; Margareth Castro Ozelo
Journal:  Blood Transfus       Date:  2013-12-03       Impact factor: 3.443

Review 2.  Immune tolerance induction for patients with severe hemophilia A: a critical literature review.

Authors:  Massimo Franchini; Giuseppe Lippi
Journal:  J Thromb Thrombolysis       Date:  2011-11       Impact factor: 2.300

3.  Frequency and epitope specificity of anti-factor VIII C1 domain antibodies in acquired and congenital hemophilia A.

Authors:  Joerg Kahle; Aleksander Orlowski; Diana Stichel; John F Healey; Ernest T Parker; Marc Jacquemin; Manuela Krause; Andreas Tiede; Dirk Schwabe; Pete Lollar; Christoph Königs
Journal:  Blood       Date:  2017-05-15       Impact factor: 22.113

Review 4.  Gene therapy for haemophilia: prospects and challenges to prevent or reverse inhibitor formation.

Authors:  David W Scott; Jay N Lozier
Journal:  Br J Haematol       Date:  2011-11-07       Impact factor: 6.998

Review 5.  Treatment Options in Hemophilia.

Authors:  Wolfgang Miesbach; Joachim Schwäble; Markus M Müller; Erhard Seifried
Journal:  Dtsch Arztebl Int       Date:  2019-11-22       Impact factor: 5.594

6.  The impact of von Willebrand factor on factor VIII memory immune responses.

Authors:  Juan Chen; Jocelyn A Schroeder; Xiaofeng Luo; Qizhen Shi
Journal:  Blood Adv       Date:  2017-08-18

7.  High-dose factor VIII inhibits factor VIII-specific memory B cells in hemophilia A with factor VIII inhibitors.

Authors:  Christina Hausl; Rafi U Ahmad; Maria Sasgary; Christopher B Doering; Pete Lollar; Günter Richter; Hans Peter Schwarz; Peter L Turecek; Birgit M Reipert
Journal:  Blood       Date:  2005-08-09       Impact factor: 22.113

Review 8.  Management of haemophilia A-inhibitor patients: clinical and regulatory perspectives.

Authors:  Zera Tellier; Marie-Hélène André; Benoît Polack
Journal:  Clin Rev Allergy Immunol       Date:  2009-10       Impact factor: 8.667

Review 9.  Antidrug Antibody Formation in Oncology: Clinical Relevance and Challenges.

Authors:  Emilie M J van Brummelen; Willeke Ros; Gertjan Wolbink; Jos H Beijnen; Jan H M Schellens
Journal:  Oncologist       Date:  2016-07-20

10.  Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment.

Authors:  Jinhai Wang; Jay Lozier; Gibbes Johnson; Susan Kirshner; Daniela Verthelyi; Anne Pariser; Elizabeth Shores; Amy Rosenberg
Journal:  Nat Biotechnol       Date:  2008-08       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.